MOLNUPAC Trademark

Trademark Overview


On Wednesday, September 21, 2022, a trademark application was filed for MOLNUPAC with the United States Patent and Trademark Office. The USPTO has given the MOLNUPAC trademark a serial number of 79369233. The federal status of this trademark filing is REGISTERED as of Tuesday, June 4, 2024. This trademark is owned by Pacific Pharmaceuticals Pte Ltd.. The MOLNUPAC trademark is filed in the Pharmaceutical Products category with the following description:

Mineral dietary supplements for humans; pharmaceutical drugs, namely, anti-viral drugs in the nature of preparations for the treatment of Coronavirus infection
molnupac

General Information


Serial Number79369233
Word MarkMOLNUPAC
Filing DateWednesday, September 21, 2022
Status700 - REGISTERED
Status DateTuesday, June 4, 2024
Registration Number7404244
Registration DateTuesday, June 4, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesMineral dietary supplements for humans; pharmaceutical drugs, namely, anti-viral drugs in the nature of preparations for the treatment of Coronavirus infection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePacific Pharmaceuticals Pte Ltd.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressSG

Party NamePacific Pharmaceuticals Pte Ltd.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressSG

Party NamePacific Pharmaceuticals Pte Ltd.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressSG

Trademark Events


Event DateEvent Description
Thursday, May 11, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 16, 2023APPLICATION FILING RECEIPT MAILED
Monday, July 3, 2023ASSIGNED TO EXAMINER
Friday, July 7, 2023NON-FINAL ACTION WRITTEN
Saturday, July 8, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 14, 2023REFUSAL PROCESSED BY MPU
Monday, August 14, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 5, 2023REFUSAL PROCESSED BY IB
Wednesday, February 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 4, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 4, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 19, 2024FINAL DISPOSITION PROCESSED
Tuesday, November 19, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, December 7, 2024FINAL DECISION TRANSACTION PROCESSED BY IB